Cumberland’s development team has a proven track record of identifying, developing, and registering specialty pharmaceutical products.

Another component of Cumberland’s growth strategy is to build upon this success and actively seek new product candidates to expand our pipeline.  We seek products that fit within the strategic focus of our company and can address unmet or poorly met medical needs. 

Our business development efforts are led by a multi-disciplinary team with significant pharmaceutical and transactional expertise.  We proactively seek out and evaluate product candidates from a variety of sources, including our international network of advisors.  Highly critical selection criteria guide our acquisition strategy as we pursue new development stage assets that fit our medical expertise and commercial capabilities.  We believe our current product portfolio is representative not only of our discriminating efforts but also of the types of opportunities we seek.

These efforts allow Cumberland to selectively build a portfolio of differentiated, safe, and effective products for underserved patient populations.